URGN logo

UroGen Pharma (URGN) Cash From Operations

Annual CFO

-$96.77 M
-$20.39 M-26.70%

December 31, 2024


Summary


Performance

URGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherURGNcash flowmetrics:

Quarterly CFO

-$13.62 M
+$14.04 M+50.77%

December 1, 2024


Summary


Performance

URGN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherURGNcash flowmetrics:

TTM CFO

-$96.77 M
-$623.00 K-0.65%

December 1, 2024


Summary


Performance

URGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherURGNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

URGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-26.7%+50.8%-0.7%
3 y3 years-14.0%+32.1%-14.0%
5 y5 years-36.3%+47.6%-36.3%

URGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-26.7%at low-4.8%+57.1%-26.7%at low
5 y5-year-36.3%+8.6%-4.8%+61.8%-36.3%+12.5%
alltimeall time-2410.0%+8.6%-624.4%+61.8%-3425.2%+12.5%

UroGen Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$96.77 M(+26.7%)
-
-
Dec 2024
-
-$13.62 M(-50.8%)
-$96.77 M(+0.6%)
Sep 2024
-
-$27.66 M(+16.5%)
-$96.14 M(+12.1%)
Jun 2024
-
-$23.75 M(-25.2%)
-$85.78 M(+4.2%)
Mar 2024
-
-$31.73 M(+144.2%)
-$82.30 M(+7.8%)
Dec 2023
-$76.38 M(-12.8%)
-$13.00 M(-24.9%)
-$76.38 M(-10.3%)
Sep 2023
-
-$17.30 M(-14.7%)
-$85.13 M(-0.4%)
Jun 2023
-
-$20.27 M(-21.4%)
-$85.44 M(-4.4%)
Mar 2023
-
-$25.81 M(+18.6%)
-$89.37 M(+2.1%)
Dec 2022
-$87.56 M(+3.1%)
-$21.75 M(+23.5%)
-$87.56 M(+2.0%)
Sep 2022
-
-$17.61 M(-27.2%)
-$85.88 M(-1.0%)
Jun 2022
-
-$24.20 M(+0.8%)
-$86.74 M(+6.4%)
Mar 2022
-
-$24.00 M(+19.6%)
-$81.49 M(-4.0%)
Dec 2021
-$84.89 M(-19.8%)
-$20.07 M(+8.6%)
-$84.89 M(-1.4%)
Sep 2021
-
-$18.48 M(-2.5%)
-$86.06 M(-7.1%)
Jun 2021
-
-$18.95 M(-30.9%)
-$92.67 M(-5.1%)
Mar 2021
-
-$27.40 M(+29.0%)
-$97.65 M(-7.8%)
DateAnnualQuarterlyTTM
Dec 2020
-$105.89 M(+49.1%)
-$21.24 M(-15.3%)
-$105.89 M(-4.3%)
Sep 2020
-
-$25.08 M(+4.8%)
-$110.64 M(+12.8%)
Jun 2020
-
-$23.93 M(-32.8%)
-$98.09 M(+10.6%)
Mar 2020
-
-$35.63 M(+37.1%)
-$88.72 M(+24.9%)
Dec 2019
-$71.02 M(+90.2%)
-$26.00 M(+107.5%)
-$71.02 M(+28.4%)
Sep 2019
-
-$12.53 M(-13.9%)
-$55.30 M(+6.2%)
Jun 2019
-
-$14.55 M(-18.8%)
-$52.05 M(+14.0%)
Mar 2019
-
-$17.93 M(+74.4%)
-$45.64 M(+22.3%)
Dec 2018
-$37.33 M(+290.2%)
-$10.28 M(+10.8%)
-$37.33 M(+13.1%)
Sep 2018
-
-$9.28 M(+13.9%)
-$33.01 M(+56.2%)
Jun 2018
-
-$8.15 M(-15.3%)
-$21.13 M(+28.5%)
Mar 2018
-
-$9.62 M(+61.5%)
-$16.45 M(+71.9%)
Dec 2017
-$9.57 M(-328.4%)
-$5.96 M(-329.5%)
-$9.57 M(+165.1%)
Sep 2017
-
$2.60 M(-175.0%)
-$3.61 M(-41.8%)
Jun 2017
-
-$3.46 M(+26.1%)
-$6.21 M(+126.1%)
Mar 2017
-
-$2.75 M
-$2.75 M
Dec 2016
$4.19 M(-158.4%)
-
-
Dec 2015
-$7.17 M
-
-

FAQ

  • What is UroGen Pharma annual cash flow from operations?
  • What is the all time high annual CFO for UroGen Pharma?
  • What is UroGen Pharma annual CFO year-on-year change?
  • What is UroGen Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for UroGen Pharma?
  • What is UroGen Pharma quarterly CFO year-on-year change?
  • What is UroGen Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for UroGen Pharma?
  • What is UroGen Pharma TTM CFO year-on-year change?

What is UroGen Pharma annual cash flow from operations?

The current annual CFO of URGN is -$96.77 M

What is the all time high annual CFO for UroGen Pharma?

UroGen Pharma all-time high annual cash flow from operations is $4.19 M

What is UroGen Pharma annual CFO year-on-year change?

Over the past year, URGN annual cash flow from operations has changed by -$20.39 M (-26.70%)

What is UroGen Pharma quarterly cash flow from operations?

The current quarterly CFO of URGN is -$13.62 M

What is the all time high quarterly CFO for UroGen Pharma?

UroGen Pharma all-time high quarterly cash flow from operations is $2.60 M

What is UroGen Pharma quarterly CFO year-on-year change?

Over the past year, URGN quarterly cash flow from operations has changed by +$14.04 M (+50.77%)

What is UroGen Pharma TTM cash flow from operations?

The current TTM CFO of URGN is -$96.77 M

What is the all time high TTM CFO for UroGen Pharma?

UroGen Pharma all-time high TTM cash flow from operations is -$2.75 M

What is UroGen Pharma TTM CFO year-on-year change?

Over the past year, URGN TTM cash flow from operations has changed by -$623.00 K (-0.65%)